Amendment to Quarterly Report — Form 10-Q Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: 10-Q/A Amendment to Quarterly Report HTML 22K
2: EX-31.1 Certification per Sarbanes-Oxley Act (Section 302) HTML 18K
3: EX-31.2 Certification per Sarbanes-Oxley Act (Section 302) HTML 17K
4: EX-32.1 Certification per Sarbanes-Oxley Act (Section 906) HTML 10K
5: EX-32.2 Certification per Sarbanes-Oxley Act (Section 906) HTML 9K
(Registrant’s
Telephone Number, Including Area Code)
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. YES o
NO x
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a nonaccelerated filer (as defined in Rule 12b-2 of
the Exchange Act). Check one:
Large
accelerated filer o
Accelerated
filer o
Nonaccelerated
filer x
Indicate
by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act):
OPKO
Health, Inc. (“the Company”) is filing this Amendment No. 1 on Form 10-Q/A for
purposes of removing Exhibit 99.1 Financial Statements of Ophthalmic
Technologies, Inc., from its previously filed Quarterly Report on Form 10-Q
filed with the Securities and Exchange Commission on August 13, 2007. In the
Company's 8-K/A to be filed on October 24, 2008, the Company will
file restated financial statements of Ophthalmic Technologies, Inc. along
with pro forma financial statements relating to its equity investment
in Ophthalmic Technologies, Inc.
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
caused this Report on Form 10-Q/A to be signed on its behalf by the undersigned
thereunto duly authorized.
Certification
by Phillip Frost, MD, Chief Executive Officer, pursuant to Rule 13a-14(a)
or 15d-14(a) of the Securities and Exchange Act of 1934 as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for the
quarterly period ended June 30, 2007.
Certification
by Rao Uppaluri, Chief Financial Officer, pursuant to Rule 13a-14(a)
or
15d-14(a) of the Securities and Exchange Act of 1934 as adopted
pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002 for the quarterly
period
ended June 30, 2007.
Certification
by Phillip Frost, MD, Chief Executive Officer, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act
of 2002 for the quarterly period ended June 30, 2007.
Certification
by Rao Uppaluri, Chief Financial Officer, pursuant to 18 U.S.C.
Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
for the quarterly period ended June 30,2007.
3
Dates Referenced Herein and Documents Incorporated by Reference
